INVERSION OF CHROMOSOME-11, INV(11)(P15Q22), AS A RECURRING CHROMOSOMAL ABERRATION ASSOCIATED WITH DE-NOVO AND SECONDARY MYELOID MALIGNANCIES - IDENTIFICATION OF A P1 CLONE SPANNING THE 11Q22 BREAKPOINT
H. Kobayashi et al., INVERSION OF CHROMOSOME-11, INV(11)(P15Q22), AS A RECURRING CHROMOSOMAL ABERRATION ASSOCIATED WITH DE-NOVO AND SECONDARY MYELOID MALIGNANCIES - IDENTIFICATION OF A P1 CLONE SPANNING THE 11Q22 BREAKPOINT, Genes, chromosomes & cancer, 19(3), 1997, pp. 150-155
We studied four patients with inv(11)(p15q22) associated with malignan
t myeloid diseases by using fluorescence in situ hybridization (FISH)
with phage and cosmid probes mapped and ordered on 11q22-24. Two of th
e four patients had non-Hodgkin's lymphoma or acute lymphoblastic leuk
emia as the primary malignancy and had received cytotoxic chemotherapy
, including topoisomerase II inhibitors. The other Mo had de novo acut
e myeloid leukemia or myelodysplastic syndrome. FISH analysis showed t
hat all I Iq breakpoints were located centromeric to the MLL gene and
between cosmids CN2900 and CN1323. We identified a yeast artificial ch
romosome (YAC) clone that spanned the inv(11) breakpoints on 11q. From
this YAC, we identified a PI clone, which included the breakpoints in
at least three of the four patients. It is highly likely that the sam
e gene on the PI clone is rearranged in leukemic cells of each patient
. This gene may be one of the targets for topoisomerase II inhibitors.
(C) 1997 Wiley-Liss, Inc.